Last reviewed · How we verify

NCT03338309: INTERPRET

INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry

Active, enrolled Last updated 14 March 2025
What this trial tests

trial testing Instantaneous wave-free ratio measurement in Stable Angina in 1,200 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 November 2017
Primary endpoint
1 December 2025
1 December 2025

Quick facts

Lead sponsorSamsung Medical Center
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment1,200
Start date1 November 2017
Primary completion1 December 2025
Estimated completion1 December 2025
Sites4 locations across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

18 and older, any sex, with Stable Angina or Non ST Segment Elevation Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study sought to evaluate the clinical relevance of iFR-guided strategy in real world clinical practice using unrestricted study population from stable angina to acute coronary syndrome including acute ST-segment elevation myocardial infarction. Previous abundant historical data of FFR-guided strategy will be also included as historical control to validate the iFR-guided strategy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stable Angina

Currently open trials in the same condition.

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03338309.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing